DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Adams S, Loi S, Toppmeyer D. et al.
Abstract PD6-10: KEYNOTE-086 cohort B: Pembrolizumab monotherapy for PD-L1–positive, previously untreated, metastatic triple-negative breast cancer (mTNBC).
Cancer Res 2018;
78: PD6-10-PD16-10
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.